Partner With Us NRI

Company details

6M Return -13.42%
1Y Return -1.46%
Mkt Cap.(Cr) 43,442.07
Volume 252
Div Yield 2.39%
OI Chg %
Volume 252

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 714.27 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 23,827.16 -46,760.12
LAST 3M 69,266.52 -85,710.05
LAST 6M 140,902.25 -216,196.87
LAST 12M 235,226.83 -247,499.26


  • About Company
  • Company Info
  • Listing Info
  • Procter & Gamble Hygiene and Health Care Limited (P & G) is engaged in ayurvedic and sanitary napkins with a market capitalisation of Rs. 13,038.55 crores as of 24th August '2021. It has featured its revenue income from operations of Rs. 2787.55 crores at the end of March 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500459 and scrip code PGHH. As of June 2021, Abbott India Limited was trading at Rs. 12331.18.

    Richardson Hindustan (RHL) was established in 1964 as a public ltd company. P & G operates through three different entities in India, of which two are listed entities, i.e. ‘Procter & Gamble Hygiene and Health care Limited’ and ‘Gillette India Limited. Its headquarters office is in Mumbai, Maharashtra. It follows July-June Financial Year. The company has 67% of the total revenue from sanitary napkins, and 32% of the revenue is from Ayurvedic products. As of 30th June '2020, your company had a total of 424 permanent employees, including 96 permanent women employees. Four hundred forty-seven persons were engaged on a temporary/contractual basis. The corporate does not have an associate or subsidiary. The promoter & promoter group holding in the company has remained constant since the last year, i.e., 70.64%, rest of the stake is held by Mutual Funds (4.88%), alternate Investment funds (0.05%), foreign portfolio investors (3.36%), Financial Institutions/Banks (3.91%), Insurance Companies (3.26%) and others (13.9%).

    In March 2021, the company profit is Rs. 98.33 crores, which had increased by 7.35% from Rs. 91.10 crores in the year-ago period. Average net income of the company for the last three Financial years Rs. 616.90 crores. From Rs. 12.91 crores in June 2019, P & G EPS has risen to Rs. 13.34 crores in June 2020. The company delivered sales of Rs. 3002 crores, up 2% against a year ago and Profit after Tax (PAT) of Rs. 433 crores, up 3% vs year ago.

    P & G stock closed at Rs. 12,683.67 on 23rd August 2021 (NSE) and has returned 12.79% in the last six months (On 23rd March 2021 stock market price Rs. 11,060.88) and 34.29% in the previous year.

Read More

No Data Found

AGM Date (Month) : Nov
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500459
Book Closure Date (Month) : Nov
BSE Group : A
ISIN : INE179A01014

ICICIdirect Procter & Gamble Hygiene and Health Care Ltd FAQ

You can buy Procter & Gamble Hygiene and Health Care Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Procter & Gamble Hygiene and Health Care Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 29, 2022 04:01 PM the closing price of Procter & Gamble Hygiene and Health Care Ltd was ₹ 13,382.85.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 29, 2022 04:01 PM, the market cap of Procter & Gamble Hygiene and Health Care Ltd stood at ₹ 43,442.07.
The latest PE ratio of Procter & Gamble Hygiene and Health Care Ltd as of Jun 29, 2022 04:01 PM is 73.51
The latest PB ratio of Procter & Gamble Hygiene and Health Care Ltd as of Jun 29, 2022 04:01 PM is 0.02
The 52-week high of Procter & Gamble Hygiene and Health Care Ltd is ₹ 16,466.40 while the 52-week low is ₹ 12,342.20 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote